Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BBWor rat

被引:10
作者
Ellerman, KE [1 ]
Like, AA [1 ]
机构
[1] Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA
关键词
D O I
10.2337/diabetes.48.5.975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 1 diabetes is a major histocompatibility complex (MHC) class II-associated autoimmune disease mediated by beta-cell-specific T-cells and characterized by circulating autoantibodies to beta-cell molecules. In the BB/Wor diabetes-prone (DP) rat, type 1 diabetes develops spontaneously with an incidence of >90%, BE diabetes can be adoptively transferred to naive syngeneic or MHC class II-compatible rats with islet cell-activated T-cell lines derived from diabetic BB/Wor rats. However, the target beta-cell autoantigen(s) in BE diabetes has not yet been defined. BE rat T-cell lines activated in vitro with antigen-presenting cells (APC) and BE islet cell crude membranes (CM), but not islet cell cytosol, adoptively transfer diabetes into young DP recipients. To determine if the target autoantigen is an integral or peripheral membrane protein, islet cell CM were treated with 0.5 mol/l KCI or 0.2 mol/l Na2CO3 (pH 11), Both treatments selectively extract peripheral proteins from the cell membrane without affecting the disposition of integral (transmembrane) proteins. T-cell lines activated in vitro with APC and 0.5mol/l KCl, or pH 11 (0.2 mol/l Na2CO3)-treated islet cell CM, transferred diabetes into young DP rats. Conversely, T-cell Lines activated in vitro with APC and the supernatant of 0.5 mol/l KCl-treated CM (containing extracted peripheral proteins), did not adoptively transfer diabetes. After activation in vitro with islet cell membrane antigens, the diabetes-inducing cell lines were comprised of both CD4(+) CD8(-) T-cells and 10-30% B-cells, We conclude that a major CD4(+) T-cell target autoantigen in BE diabetes is a membrane-associated beta-cell molecule with the characteristics of an integral beta-cell membrane protein. The identification of this MHC class II-restricted beta-cell target molecule will allow the design of antigen-specific intervention protocols to prevent the onset of type 1 diabetes in genetically susceptible individuals.
引用
收藏
页码:975 / 982
页数:8
相关论文
共 47 条
[1]   Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD(65) and IA2 marks the early phases of autoimmune response in type 1 diabetes [J].
Aanstoot, HJ ;
Kang, SM ;
Kim, J ;
Lindsay, LA ;
Roll, U ;
Knip, M ;
Atkinson, M ;
MoseLarsen, P ;
Fey, S ;
Ludvigsson, J ;
Landin, M ;
Bruining, J ;
Maclaren, N ;
Akerblom, HK ;
Baekkeskov, S .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2772-2783
[2]   Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice [J].
Akashi, T ;
Nagafuchi, S ;
Anzai, K ;
Kondo, S ;
Kitamura, D ;
Wakana, S ;
Ono, J ;
Kikuchi, M ;
Niho, Y ;
Watanabe, T .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (08) :1159-1164
[3]   Pex14p, a peroxisomal membrane protein binding both receptors of the two PTS-dependent import pathways [J].
Albertini, M ;
Rehling, P ;
Erdmann, R ;
Girzalsky, W ;
Kiel, JAKW ;
Veenhuis, M ;
Kunau, WH .
CELL, 1997, 89 (01) :83-92
[4]  
ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
[5]   AUTOANTIBODIES TO A 64-KILODALTON ISLET CELL PROTEIN PRECEDE THE ONSET OF SPONTANEOUS DIABETES IN THE BB RAT [J].
BAEKKESKOV, S ;
DYRBERG, T ;
LERNMARK, A .
SCIENCE, 1984, 224 (4655) :1348-1350
[6]   IDENTIFICATION OF THE 64K AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES AS THE GABA-SYNTHESIZING ENZYME GLUTAMIC-ACID DECARBOXYLASE [J].
BAEKKESKOV, S ;
AANSTOOT, HJ ;
CHRISTGAU, S ;
REETZ, A ;
SOLIMENA, M ;
CASCALHO, M ;
FOLLI, F ;
RICHTEROLESEN, H ;
CAMILLI, PD .
NATURE, 1990, 347 (6289) :151-156
[7]   GRASP65, a protein involved in the stacking of Golgi cisternae [J].
Barr, FA ;
Puype, M ;
Vandekerckhove, J ;
Warren, G .
CELL, 1997, 91 (02) :253-262
[8]   ISLET-SPECIFIC T-CELL CLONES FROM THE NOD MOUSE RESPOND TO BETA-GRANULE ANTIGEN [J].
BERGMAN, B ;
HASKINS, K .
DIABETES, 1994, 43 (02) :197-203
[9]  
CASTLE JD, 1995, CURRENT PROTOCOLS PR
[10]   SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES [J].
CHICZ, RM ;
URBAN, RG ;
GORGA, JC ;
VIGNALI, DAA ;
LANE, WS ;
STROMINGER, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :27-47